Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
Julie had a routine health check at 69 and it found a life-threatening condition ...
Are you standing in the way of creativity?
Julie James, 71, had ‘no symptoms at all’ that showed something might be wrong.
Explore how evolution shaped our brains to lie, revealing the complex interplay between deception, survival, and social ...
ADHD attention circuit research from Johns Hopkins University has identified PLTi — an ancient brainstem cluster of ...
Millions of adults over 50 who faithfully hit the federal daily target of 2.4 micrograms of vitamin B12 may still be leaving ...
"Eat more sugar," said nobody ever. Why? Well, sugar provides only calories, and in a country where obesity and its attendant ...
Primary hyperaldosteronism may account for a sizable share of resistant hypertension, yet experts say most cases still go ...
Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome June 29, 2026 8:00 AM EDTCompany ParticipantsLina ...